News & Insights
The European Commission has opened a public consultation on legislation relating to plants produced by certain genomic techniques The consultation is open for submissions until midnight (CET) on the… read more…
The European Patent Office (EPO) has a growing body of case law relating to the significance of clinical trial protocols when assessing novelty and inventive step The latest in this line of… read more…
Data provided by Mathys & Squire has featured in an article by The Times, Tech Register, World Intellectual Property Review, Institute of Export and International Trade and City… read more…
UPDATE as of 19 October 2023 The European Patent Office (EPO)’s ‘10-day rule’ will cease to exist from 1 November 2023 From that date, EPO communications will be deemed to be delivered on… read more…
Data provided by Mathys & Squire has featured in an article by The Trademark Lawyer, highlighting a surge in trade marks owned by online fast fashion retailers The number of trade… read more…
The 2022 edition of Managing IP’s IP STARS directory has now been released and Mathys & Squire is delighted to have six practitioners named ‘IP Stars’ We are pleased to… read more…
Data provided by Mathys & Squire has featured in an article by City AM highlighting UK litigation funders’ increased interest in intellectual property cases Click here to read the… read more…
(C) Naomi Korn Associates & Mathys & Squire 2022 Some Rights Reserved These case studies are licensed for reuse under the terms of a Creative Commons Attribution Share Alike… read more…
We are pleased to announce the appointment of a biotech Partner Iain Armstrong Iain has over 20 years’ experience advising clients in the life sciences field, providing practical and pragmatic… read more…
Mathys & Squire uses cookies
We use cookies to ensure you get the best experience on our website. More details are available via our Cookie Policy.